Roxane Recalls Oxycodone Oral Solution Due to Stability Failure
Boehringer Ingelheim Roxane recalls specific lots of Oxycodone Hydrochloride Oral Solution due to failed preservative stability specifications.
Use caution until it’s fixed
Failed Stability Specifications: Out of specification result for preservative sodium benzoate.
Contact the company
What happened, in plain English
Boehringer Ingelheim Roxane Inc is recalling a small quantity of Oxycodone Hydrochloride C II Oral Solution because it failed stability specifications. Specifically, the preservative sodium benzoate was found to be out of specification. The recall affects 2,149 bottles distributed nationwide. Read more at govinfonow.com/recall/45927-boehringer-ingelheim-roxane-inc-recalls-oxycodone-hydrochloride-c-ii-oral.
Source Summary by GovInfoNow · govinfonow.com/recall/45927-boehringer-ingelheim-roxane-inc-recalls-oxycodone-hydrochloride-c-ii-oral · Updated October 12, 2026 · FDA enforcement record: FDA #D-1486-2014
Cite this page
“Roxane Recalls Oxycodone Oral Solution Due to Stability Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45927-boehringer-ingelheim-roxane-inc-recalls-oxycodone-hydrochloride-c-ii-oral. Based on FDA recall #D-1486-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1486-2014%22&limit=1).
Why it’s dangerous
The preservative sodium benzoate in the solution was found to be out of specification, meaning it did not meet stability requirements. This failure could potentially compromise the integrity of the medication, although the specific health consequences are not detailed in the record.
Who’s affected
Patients who have been prescribed this specific formulation of oxycodone oral solution by a healthcare provider are the ones affected. Those who purchased or were dispensed the recalled lot numbers are at risk of receiving a product that may not maintain its intended potency or safety profile over time.
How to tell if you have this one
Check if you have Oxycodone Hydrochloride C II Oral Solution USP, 5 mg/5 mL, in a 15 mL vial. Look for NDC 0054-0523-41 and Lot # 360241A with an expiry date of 05/2015. The product was distributed nationwide in the U.S.
- Brand
Roxane- Category
Drug
What to do — step by step
Contact Your Pharmacist
Reach out to your pharmacy or healthcare provider to determine if you have been dispensed the recalled lot and to discuss next steps for replacement or disposal.
Do Not Use Recalled Product
If you possess the specific lot number 360241A, do not use the medication until you have received guidance from your healthcare provider.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many bottles were recalled?
A total of 2,149 bottles were included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1486-2014 (July 28, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1486-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.